Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
Main Authors: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2012
|
פריטים דומים
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
מאת: Kampoli, A, et al.
יצא לאור: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
מאת: Briasoulis, A, et al.
יצא לאור: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
מאת: Tousoulis, D, et al.
יצא לאור: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
מאת: Gounari, P, et al.
יצא לאור: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
מאת: Tousoulis, D, et al.
יצא לאור: (2011)